Farming > Horticulture
Our goal is to fundamentally change the way people think about cancer treatment by pushing the boundaries of what is possible with cell therapy — using genetically modified immune cells to target tumors.
Our engineered cell therapies express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. This dual platform has the potential to transform cancer treatment by addressing the goal of treating both hematological cancers and solid tumors.
Details
- Last Updated
- 15/Jul/2024
- Contact
- Christi Shaw
- [email protected]
- Phone
- (310) 824-9999
- Website
- http://www.kitepharma.com/
- Address
- 2225 Colorado AveSanta Monica, CA 90404